Cue Health Inc. (HLTH)
After hours:
| Previous close | 0.0943 |
| Open | 0.1235 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 0.0911 - 0.1380 |
| 52-week range | 0.0810 - 0.7770 |
| Volume | |
| Avg. volume | 7,018,701 |
| Market cap | 14.716M |
| Beta (5Y monthly) | 1.30 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.4400 |
| Earnings date | 07 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 0.75 |
- Business Wire
Cue Health Evaluating Warning Letter Received from Food and Drug Administration (FDA)
SAN DIEGO, May 14, 2024--Cue Health Inc. (Nasdaq: HLTH), a healthcare technology company (the "Company"), has received a warning letter from the FDA about its Emergency Use Authorized (EUA) COVID-19 test. The Company is currently evaluating the letter and determining its response, with more information to follow in the next few days.
- Business Wire
Cue Health to Announce First Quarter Financial Results
SAN DIEGO, April 29, 2024--Cue Health Inc. ("Cue") (Nasdaq: HLTH), a healthcare technology company, announced today that it will release its first quarter 2024 financial results on Monday, May 13, 2024. The company will not be hosting a conference call.
- Business Wire
Cue Health Announces Strategic Actions to Position Company for Next Stage
SAN DIEGO, March 20, 2024--Cue Health Inc. ("Cue" or the "Company") (Nasdaq: HLTH), a healthcare technology company, today announced strategic actions implemented by its Board of Directors (the "Board") to best position the Company for its next stage:
